SCHEMBL27104751

SCHEMBL27104751

O/N=C(\Nc1ccc(F)c(Br)c1)c1nonc1NCC1CCN(SC2CC2)C1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22592604 0.94 IDO1 (0.52) IDO1
SCHEMBL22592632 0.89 IDO1 (0.57) IDO1
SCHEMBL22592467 0.87 IDO1 (0.56) IDO1
SCHEMBL22592658 0.87 IDO1 (0.72) IDO1
SCHEMBL22592599 0.87 IDO1 (0.72) IDO1
SCHEMBL2513839 0.85 IDO1 (0.66) IDO1
SCHEMBL2513832 0.85 IDO1 (0.66) IDO1
SCHEMBL28557185 0.84 IDO1 (0.59) IDO1
SCHEMBL27103851 0.84 IDO1 (0.57) IDO1
SCHEMBL22592595 0.84 IDO1 (0.74) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3730484-B1 INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF HINOVA PHARMACEUTICALS INC (CN) 2024-02-28 EP disclosed